2-D Diffusion Assay on Polymer Brush for POC Cardiac Infarction Diagnosis

用于 POC 心肌梗死诊断的聚合物刷二维扩散测定

基本信息

  • 批准号:
    8354709
  • 负责人:
  • 金额:
    $ 23.06万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-07-17 至 2014-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The objective of this R21 proposal is to develop a multianalyte 2-D diffusion point-of-care assay (POC) for cardiac infarction. The 2-D diffusion assay consists of a "nonfouling" poly(oligoethyene glycol methacrylate (POEGMA) brush coated glass chip that contains two types of printed spots: "stable" spots of capture antibodies (Abc) and "soluble" spots of detection reagents that are printed with excipients so that they dissolve upon contact with blood. A finger stick of blood is applied to the surface, and the protein analytes in the blood diffuse across the nonfouling POEGMA brush and bind to immobile spots of the individual capture antibodies (Abc's) on the surface. Simultaneously, the blood dissolves the fluorescently labeled detection Ab's (Abd) from the labile spots, which then bind to their respective analyte-Abc spots, completing the sandwich. A final displacement step with buffer removes the blood components from the chip, revealing the formation of a fluorescent spot at the position where the unlabeled detection agent had been printed. This assay will require no sample preprocessing, will be multiplexed to detect cardiac troponin (cTnI) and the brain natriuretic pro-polypeptide (pro-BNP) on the same chip, and will provide quantitative read-out of analyte concentration, thereby providing a new dimension of capabilities to POC tests that are superior to the current gold standard - lateral-flow assays. PUBLIC HEALTH RELEVANCE: The proposed research will develop a new point-of-care clinical test -the 2-D diffusion assay- for cardiac infarction that requires no sample purification and minimal steps in testing. In this assay, adding a drop of blood to the surface of a thin polymer film allows a marker that is present in the patient's blood -and diagnostic of a disease- to bind to "stable" capture spots of capture antibodies, while simultaneously, the blood dissolves optically labeled detection antibodies that are printed as "soluble" spots, so that they migrate in solution to the stable spots of capture molecules bound to the marker, and complete the assay, resulting in a visible signal.
描述(由申请人提供):本R21提案的目标是开发一种用于心肌梗死的多分析二维扩散点检测(POC)。2-D扩散法由一个“无污染”聚甲基丙烯酸寡乙二醇酯(POEGMA)刷涂玻璃芯片组成,其中包含两种类型的印刷点:捕获抗体(ABC)的“稳定”点和检测试剂的“可溶”点,这些点印有辅料,使它们与血液接触时溶解。将一根手指的血液涂抹在表面,血液中的蛋白质分析物在无污染的POEGMA刷子上扩散,并与表面上个人捕获抗体(ABC)的固定斑点结合。同时,血液从不稳定的斑点溶解荧光标记的检测抗体(ABD),然后结合到各自的分析物-ABC斑点,完成三明治。使用缓冲液的最后置换步骤从芯片中移除血液成分,揭示在打印未标记的检测剂的位置形成的荧光点。该分析不需要样品前处理,将在同一芯片上多路复用以检测心肌肌钙蛋白(CTnI)和脑钠素前体多肽(Pro-BNP),并将提供分析物浓度的定量读出,从而提供优于当前金标准-侧向流动分析的POC测试能力的新维度。 与公共卫生相关:这项拟议的研究将为心肌梗死开发一种新的临床点检测方法--二维扩散法,不需要样品纯化 测试中的最小步骤。在这种化验方法中,在一层薄的聚合物膜表面滴入一滴血,就可以使患者血液中的一种标记物与捕获抗体的“稳定”捕获斑点结合,同时,血液溶解打印成“可溶”斑点的光学标记检测抗体,从而使它们迁移到 溶液将稳定的斑点捕获分子结合到标记物上,并完成检测,产生可见信号。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Ashutosh Chilkoti其他文献

Ashutosh Chilkoti的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Ashutosh Chilkoti', 18)}}的其他基金

Development, Clinical Validation, and Readiness for Implementation of a Novel Mp1p D4 Poin Diagnosis of Talaromycosist of Care Test for Rapid
新型 Mp1p D4 点诊断踝部真菌护理测试的开发、临床验证和准备实施
  • 批准号:
    10700281
  • 财政年份:
    2023
  • 资助金额:
    $ 23.06万
  • 项目类别:
Multiplex point-of-care test for diagnosis, prognosis and serology of COVID19
用于 COVID19 诊断、预后和血清学的多重即时检测
  • 批准号:
    10417262
  • 财政年份:
    2021
  • 资助金额:
    $ 23.06万
  • 项目类别:
Multiplex point-of-care test for diagnosis, prognosis and serology of COVID19
用于 COVID19 诊断、预后和血清学的多重即时检测
  • 批准号:
    10297706
  • 财政年份:
    2021
  • 资助金额:
    $ 23.06万
  • 项目类别:
Multiplex point-of-care test for diagnosis, prognosis and serology of COVID19
用于 COVID19 诊断、预后和血清学的多重即时检测
  • 批准号:
    10641013
  • 财政年份:
    2021
  • 资助金额:
    $ 23.06万
  • 项目类别:
Injectable PEG-like Conjugate for Sustained Delivery of a Peptide Drug for Type 2 Diabetes Treatment
用于持续递送肽药物治疗 2 型糖尿病的可注射 PEG 样缀合物
  • 批准号:
    10314066
  • 财政年份:
    2020
  • 资助金额:
    $ 23.06万
  • 项目类别:
Injectable PEG-like Conjugate for Sustained Delivery of a Peptide Drug for Type 2 Diabetes Treatment
用于持续递送肽药物治疗 2 型糖尿病的可注射 PEG 样缀合物
  • 批准号:
    10520019
  • 财政年份:
    2020
  • 资助金额:
    $ 23.06万
  • 项目类别:
Point-of-care cellular and molecular pathology of breast tumors on a cell phone
在手机上进行乳腺肿瘤的护理点细胞和分子病理学
  • 批准号:
    10358633
  • 财政年份:
    2020
  • 资助金额:
    $ 23.06万
  • 项目类别:
A Fully Integrated Point-of-Care Test for Ebola
完全集成的埃博拉即时护理测试
  • 批准号:
    10269019
  • 财政年份:
    2020
  • 资助金额:
    $ 23.06万
  • 项目类别:
A Fully Integrated Point-of-Care Test for Ebola
完全集成的埃博拉即时护理测试
  • 批准号:
    10468131
  • 财政年份:
    2020
  • 资助金额:
    $ 23.06万
  • 项目类别:
A Fully Integrated Point-of-Care Test for Ebola
完全集成的埃博拉即时护理测试
  • 批准号:
    10119782
  • 财政年份:
    2020
  • 资助金额:
    $ 23.06万
  • 项目类别:

相似海外基金

Novel Carbohydrate-binding Antibodies to Human Glycans Using the Lamprey System
使用 Lamprey 系统开发针对人类聚糖的新型碳水化合物结合抗体
  • 批准号:
    10454419
  • 财政年份:
    2021
  • 资助金额:
    $ 23.06万
  • 项目类别:
Novel Carbohydrate-binding Antibodies to Human Glycans Using the Lamprey System
使用 Lamprey 系统开发针对人类聚糖的新型碳水化合物结合抗体
  • 批准号:
    10672258
  • 财政年份:
    2021
  • 资助金额:
    $ 23.06万
  • 项目类别:
Novel Carbohydrate-binding Antibodies to Human Glycans Using the Lamprey System
使用 Lamprey 系统开发针对人类聚糖的新型碳水化合物结合抗体
  • 批准号:
    10293635
  • 财政年份:
    2021
  • 资助金额:
    $ 23.06万
  • 项目类别:
Computational modelling and simulation of antibodies to enhance binding affinity of a potential Burkholderia pseudomallei therapeutic
抗体的计算模型和模拟,以增强潜在的鼻疽伯克霍尔德氏菌治疗剂的结合亲和力
  • 批准号:
    2750554
  • 财政年份:
    2021
  • 资助金额:
    $ 23.06万
  • 项目类别:
    Studentship
Covalent binding Antibodies as a Chemical Tool to Probe Immune Molecular Recognition
共价结合抗体作为探测免疫分子识别的化学工具
  • 批准号:
    565778-2021
  • 财政年份:
    2021
  • 资助金额:
    $ 23.06万
  • 项目类别:
    Alexander Graham Bell Canada Graduate Scholarships - Master's
Establishment of a novel serum diagnosis method for flaviviruses based on binding profiles of anti-flavivirus antibodies
基于抗黄病毒抗体结合谱建立黄病毒新型血清诊断方法
  • 批准号:
    20J22269
  • 财政年份:
    2020
  • 资助金额:
    $ 23.06万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Role of Antigen Glycosylation in Mucin Binding by Monoclonal Antibodies
抗原糖基化在单克隆抗体粘蛋白结合中的作用
  • 批准号:
    10045898
  • 财政年份:
    2020
  • 资助金额:
    $ 23.06万
  • 项目类别:
Do anti-DNA antibodies play a role in the pathogenesis of systemic lupus erythematosus by binding/entering live cells?
抗 DNA 抗体是否通过结合/进入活细胞在系统性红斑狼疮的发病机制中发挥作用?
  • 批准号:
    16K08929
  • 财政年份:
    2016
  • 资助金额:
    $ 23.06万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
N-Terminally fluorescent-labeled antibodies that show fluorescence change upon antigen-binding
N 末端荧光标记抗体,在抗原结合时显示荧光变化
  • 批准号:
    15K13739
  • 财政年份:
    2015
  • 资助金额:
    $ 23.06万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
(i) Identification of single-molecule protein complexes involved in cellular transport of prosthetic groups (Moco and heme) (ii) Generation of monoclonal antibodies directed against protein motifs involved in binding prosthetic groups
(i) 鉴定参与假体基团(Moco 和血红素)细胞运输的单分子蛋白复合物 (ii) 生成针对参与结合假体基团的蛋白基序的单克隆抗体
  • 批准号:
    226653713
  • 财政年份:
    2012
  • 资助金额:
    $ 23.06万
  • 项目类别:
    Research Units
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了